BRKR vs MOH

The Advanced Deterministic Scorecard reveals a weak fundamental profile with a Piotroski F-Score of just 2/9, indicating poor financial health. Despite a reasonable Price/Book of 3.13 and a Forward P/E of 23.49 that is below sector average, the company is unprofitable with a negative profit margin (-0.61%) and ROE (-1.09%). Revenue is flat, earnings volatility is high, and insider selling of $2.76M over the past six months signals management skepticism. While the technical rebound from 6-month lows has lifted price performance (+20.3% over 6M), the long-term trend remains weak with a 3Y return of -28.5%, and analyst target of $54.07 appears optimistic given deteriorating fundamentals.

Molina Healthcare exhibits a stable Piotroski F-Score of 5/9, but this is overshadowed by a severe collapse in profitability and earnings quality. The company is currently trading at $151.00, which is significantly above its growth-based intrinsic value of $62.79 and its defensive Graham Number of $126.90. A rising Medical Care Ratio (MCR) of 91.7% and negative operating margins (-1.49%) indicate that rising healthcare costs are outpacing state reimbursement rates. With a 1-year price decline of 50% and a catastrophic YoY EPS growth of -154.5%, the stock appears to be in a fundamental downtrend.